Connected Programs: 
Molekulare Medizin/Biotechnologie


1. Study program and objectives (PDF)
2. Structure
3. Acceptance
4. Admission
5. Qualification and professional fields
6. Curricula


1. Study program and objectives

The field of molecularly oriented life sciences (life sciences) is experiencing an enormous upswing and is one of the key industries of the 21st centuries with enormous growth potential and career development opportunities. On the one hand, this is due to advances in biomedical research, which enable the development of new diagnostic and therapeutic procedures. On the other hand, there are more and more biotechnological methods, enabling molecular findings to be translated into products and services.

The Connected Programs in Molecular Medicine/Biotechnology are built on corresponding subject-related bachelor’s programs. The double degree program serves to advance and complete the theoretical and practical knowledge in the field of molecular biosciences and to get the comprehensive professional competence to translate this knowledge into appropriate products and services.

The combination of the existing Master’s Programs in Biotechnology (MCI) and Molecular Medicine (MUI) expands the contents of each of the programs:

      • Biotechnologists gain in-depth insights into the fundamentals of molecular medicine, in particular medical aspects of biotechnical products.
      • Molecular medical scientists are increasingly enabled to translate scientific findings into biotechnical products.


The profile resulting from the combination provides graduates with distinct competitive advantages in entering highly qualified professional employment in the entire field of modern life sciences, particularly in research and development in the biotechnology/genetics and pharmaceutical industries, in biomedical research at universities and research institutions, and in administration authorities. Furthermore, the completion of the master’s programs is the prerequisite for a continuing PhD-study program, the highest academic form of education.


2. Structure

The program is designed for 6 semesters. Half of the courses are taken at the MUI and half at the MCI. In the semesters 5 and 6, two separate and independent Master’s Theses are written.


Semester 1 (WS):


Semester 2 (SS):


Semester 3 (WS):


Semester 4 (SS):


Semester 5 and 6 (WS/SS):

Separate Master’s Theses at the MUI and MCI


1. Semester (MUI):
   Module acc. to the Master’s Program in Molecular Medicine (semester 1)

      • Mandatory Module CM 1 (Medical Interdisciplinary Courses and Mandatory Project Study)
      • Mandatory Module CM2 (Oncoscience)


2. Semester (MCI):
    Modules acc. to the Master’s Program in Biotechnology (semester 2)

      • Bioanalytics
      • Downstream Processing
      • Pharmaceutical Technology & Upstream Processing
      • Biodata Science & Scientific Methods
      • Project Biotechnology 2
      • General Management 2


3. Semester (MCI):
   Modules acc. to the Master’s Program in Biotechnology (semester 3)

      • Biopharma & Diagnostics
      • Industrial Biotechnology
      • Bioinformatics
      • Project Biotechnology 3
      • Regulatory Framework & Scientific Methods
      • General Management 3


4. Semester (MUI):
   Modules acc. to the Master’s Program in Molecular Medicine (semester 2)

      • Mandatory Module 3: Infection and Immunity
      • Elective Module: Please refer to the curriculum of the Master’s Program in Molecular Medicine for currently offered elective modules

A maximum of one elective module covering 7.5 ECTS-Credits may be replaced by a project study upon application of the student to the body responsible for study law. Project studies have an extent of 7.5 ECTS-Credits.


Semester 5/6:
         Master’s Theses and final examinations (at both institutions)

The language of instruction is English. It is mandatory to write the Master’s Theses in English.


3. Acceptance

Applicants of Connected Programs must complete both admission procedures, the one for the Master’s Programs in Molecular Medicine (MUI) and the one for Biotechnology (MCI) and must be accepted to both programs. Applicants must express interest in the Connected Programs prior to the admissions procedure at each institution as part of their registration. There are a maximum of 6 places for each year of study. After the application phase, these places are allocated to the six most suitable candidates.


Admission procedure for Molecular Medicine (MUI)

The procedure, e.g. the internet application, the procedure criteria, dates etc., for the admission to the Master’s Program in Molecular Medicine at the Medical University of Innsbruck can be found here


Admission procedure for Biotechnology (MCI)

Criteria: career history (50%), application interview by a commission (50%)

Application deadlines are usually in November, January, March and May.


Applications for the Connected Program at the MUI can only be made within the application period for a winter semester. Applications at the MCI must be made separately according to the application deadlines valid there.


4. Admission

Applicants who have been assigned a place on the final ranking list must begin their studies in person within a period of time announced in the course of the admission procedure. Failure to take up the studies on time will result in the forfeiture of the study place.
ATTENTION: Admission takes place at the respective institution.

Information on the admission


5. Qualification and professional fields

Graduates of the Connected Programs in Molecular Medicine / Biotechnology possess in-depth knowledge of both the molecular basis of medical issues and the biotechnological translation of this knowledge into pharmaceutical or diagnostic products. They work at the interface of natural sciences and engineering. On the one hand, they deal with molecular and medical methods, on the other hand with engineering methods. Graduates are qualified for independent scientific work in basic medical research as well as for the direct handling of tasks in the application-oriented areas of the development of molecular-based diagnostic and therapeutic concepts. They work with cell culture techniques, operate bioreactors and develop biotechnological processes. Graduates are able to transfer processes developed in the laboratory to the industrial scale and to be responsible for smooth processes in production.

Due to the broad, interdisciplinary education, graduates can work in a variety of fields of employment, especially in the following areas and industries.

Biomedical research and development, for example in the fields of


        • oncoscience
          • infection and immunity
          • genetics-epigenetics-genomics
          • structural biology and bioinformatics
          • molecular cell biology
          • biopharmaceutical development and production
          • diagnostics



6. Curricula

MUI (“Curriculum” section)
MCI (“Curriculum and courses” section)